Krystal Biotech (FRA:4KB) Other Long Term Assets : €0.2 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Krystal Biotech Other Long Term Assets?

Krystal Biotech's other long-term assets for the quarter that ended in Dec. 2024 was €0.2 Mil.

Krystal Biotech's quarterly other long-term assets increased from Jun. 2024 (€0.1 Mil) to Sep. 2024 (€0.2 Mil) and increased from Sep. 2024 (€0.2 Mil) to Dec. 2024 (€0.2 Mil).

Krystal Biotech's annual other long-term assets declined from Dec. 2022 (€0.3 Mil) to Dec. 2023 (€0.2 Mil) and declined from Dec. 2023 (€0.2 Mil) to Dec. 2024 (€0.2 Mil).

Krystal Biotech Other Long Term Assets Historical Data

The historical data trend for Krystal Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krystal Biotech Other Long Term Assets Chart

Krystal Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

1.33

0.07

0.31

0.24

0.22

Krystal Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															0.24	0.18	0.12	0.18	0.22

Krystal Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Krystal Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Krystal Biotech Inc (FRA:4KB) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

KRYS:USA 4KB:Germany

Address

2100 Wharton Street, Suite 701, Pittsburgh, PA, USA, 15203

Website

https://www.krystalbio.com

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Krystal Biotech Headlines

No Headlines